Catalyst Wire Dossier Catalyst Wire Dossier

VALGANCICLOVIR HYDROCHLORIDE FOR ORAL

Valganciclovir hydrochloride · Actavis Pharma, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VALGANCICLOVIR HYDROCHLORIDE FOR ORAL, covering 2016-07-18 to 2020-03-12. Get the full timeline:

Most recent: FDA Approved: VALGANCICLOVIR HYDROCHLORIDE FOR ORAL — Supplemental Application (Actavis Pharma, Inc.)

See pricing